Infinity Pharmaceuticals Inc (INFIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,492 | -29,893 | -20,359 | -10,886 | -47,057 |
| Depreciation Amortization | 483 | 364 | 242 | 120 | 219 |
| Other Working Capital | 1,385 | -30 | -733 | -1,693 | 1,383 |
| Other Operating Activity | 2,885 | 2,330 | 1,504 | 682 | 3,925 |
| Operating Cash Flow | $-35,739 | $-27,229 | $-19,346 | $-11,777 | $-41,530 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,674 | -2,544 | 6,449 | 448 | -9,914 |
| PPE Investments | -43 | -44 | -44 | -18 | -2,327 |
| Investing Cash Flow | $14,631 | $-2,588 | $6,405 | $430 | $-12,241 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,869 | 6,513 | 30 | N/A | 112 |
| Other Financing Activity | 19,572 | 19,572 | 19,572 | 19,572 | 27,618 |
| Financing Cash Flow | $27,441 | $26,085 | $19,602 | $19,572 | $27,730 |
| Beginning Cash Position | 22,575 | 22,575 | 22,575 | 22,575 | 48,616 |
| End Cash Position | 28,908 | 18,843 | 29,236 | 30,800 | 22,575 |
| Net Cash Flow | $6,333 | $-3,732 | $6,661 | $8,225 | $-26,041 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,739 | -27,229 | -19,346 | -11,777 | -41,530 |
| Capital Expenditure | -43 | -44 | -44 | -18 | -2,327 |
| Free Cash Flow | -35,782 | -27,273 | -19,390 | -11,795 | -43,857 |